BROWSE ALL ARTICLES BY TOPIC
Articles by Keyword - Patients
Listing articles 61 to 70 of 110
Features: PAC Progress and Challenges
In 2007, the ACR established a political action committee, known as RheumPAC. Three years later, the PAC has raised more than $130,000, contributed to the campaigns of dozens of senators and congress-people who support legislation that could benefit rheumatology, and attended countless meetings, fundraisers, and one-on-one discussions with federal elected officials and their staffs.
Personal stories are the most effective way to communicate an issue to Congress. No one can better illustrate the complex nature of healthcare policy decisions and how they affect medical care than those involved daily in the medical profession.
Columns: The Canes of York
After the sojourn at the Jorvik Centre, which I wrote about in last month’s column, we were off to the York Minster following a route where the traffic sounds differently than it does in the United States. The air fills with the grind and rumble of diesel engines, and the rush of doubledecker buses gives a great thump.
Departments: Another Vocabulary for Rheumatology Research
In 1991, Swiss-trained rheumatologist and rehabilitation specialist, Gerold Stucki, MD, MS, wrote to top U.S. rheumatologists Lynn Gerber, MD, then at the National Institutes of Health (NIH) in Bethesda, Md.; Robert L. Swezey, MD, then at the University of California at Los Angeles; and George Ehrlich, MD, of the University of Pennsylvania in Philadelphia, to explain that he wanted to better understand patients’ functioning and disability in relationship to their condition. He asked each person to...
Columns: Risks and Benefits
Right after I finished my PhD degree (studying, among other things, the mode of action of the antibiotic nalidixic acid), I started my medical clerkship on the wards of a venerable New York City hospital. This was the kind of hospital that in a movie would be called Fort Apache, and the physical exam of the patient would start with a search for guns and knives. There, with my very first patient, I learned important lessons about drug safety.
From the College: What Subliminal Cues Are Lurking in Your Waiting Room?
The current managed care environment and declining reimbursement rates are forcing physicians to see more patients to break even. With a constant stream of new patients and appointments booked back to back, waiting has become an unavoidable patient experience in healthcare. In fact, many patients spend more time in the waiting room than in an exam room with a physician.
Departments: Office Visit
Many physicians consider their formal education complete when they finish their residency, but for John Schousboe, MD, PhD, that was just one step on his educational journey. After training and starting practice, Dr. Schousboe returned to school to earn a masters degree in health services research and policy at the University of Minnesota, and he earned a PhD in the field at the beginning of this year—all while running an osteoporosis center. Some may wonder why this busy physician felt the urge to...
From the College: Five To-Dos for a Successful Practice in 2009
It is often a challenge for practices to keep up with all the coding changes that happen each year, and that’s why your ACR coding specialists are here.
Departments: A Regulatory Leader in Rheumatology
I’ve always been fascinated by the science of immunology, and I wanted to make basic science a part of my career,” reflects Jeffrey N. Siegel, MD, from his office at the Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) in Rockville, Md. “I thought that rheumatology was an area where the new findings from the field of immunology could be translated into clinical therapies for patients. It’s amazing how true that has turned out to be.”
You sit down at your partner’s desk at the end of a long day seeing patients in the office. You say aloud, “Things were going great until that last patient. She really took me out. She was mad at me for saying that the low-titer ANA [antinuclear antibodies] was not an issue and that she had only fibromyalgia. Go figure.”